Drug
Cromakalim clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Name
Studies by the year they started
10 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 10
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 10
Studies
Open first, then newest update. How each study uses Cromakalim is read from its arms, and is right about nine times in ten.
Testing it · 10
- Effect of Levcromakalim in Individuals With Migraine Pretreated With ErenumabCompletedNot applicableDanish Headache CenterNCT05889442Written as Levcromakalim
- The Effects of Levcromakalim in Patients With Cluster HeadacheCompletedNot applicableDanish Headache CenterNCT05093582Written as Levcromakalim
- Migraine Inducing Effect of Levcromakalim in Patients With Migraine With AuraCompletedNot applicableDanish Headache CenterNCT04905654Written as Levcromakalim
- The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.Status unknownNot applicableDanish Headache CenterNCT05565001Written as Levcromakalim
- Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic HeadacheCompletedNot applicableDanish Headache CenterNCT05243953Written as Levcromakalim
- The Hemodynamics Effect of Glibenclamide on Levcromakalim Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study With Healthy VolunteersStatus unknownNot applicableDanish Headache CenterNCT03886922Written as Levcromakalim
- The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.CompletedNot applicableDanish Headache CenterNCT03609008Written as Levcromakalim
- Headache Inducing Effect of Levcromakalim in Migraine With Aura PatientsCompletedNot applicableDanish Headache CenterNCT04012047Written as Levcromakalim
- Peripheral Nociceptive Effects of LevcromakalimCompletedNot applicableDanish Headache CenterNCT03726242Written as Levcromakalim
- Headache Inducing Effect of Cromakalim in Migraine PatientsCompletedNot applicableDanish Headache CenterNCT03228355Written as Levcromakalim
Given in every arm · 2 — Cromakalim is usual care beside what is tested
- Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)CompletedNot applicableDanish Headache CenterNCT04853797Written as Levcromakalim
- Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With MigraineCompletedNot applicableDanish Headache CenterNCT05211050Written as Levcromakalim
Codes
What other systems call Cromakalim · ClinicalTrials.gg INT008724
- MeSH (NLM) D019806CromakalimConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0G4X367WA3CROMAKALIMConfirmed FDA, NLM, Wikidata
- Wikidata Q3698301cromakalimConfirmed FDA, NLM, Wikidata
- Wikidata Q76009683levcromakalimConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C79109CromakalimOne source FDA
- DrugBank DB21154One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019806 | Cromakalim | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0G4X367WA3 | CROMAKALIM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3698301 | cromakalim | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q76009683 | levcromakalim | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C79109 | Cromakalim | One source FDA |
| DrugBank | DB21154 | — | One source Wikidata |
Also registered as levcromakalim (UNII RW7PN4BLDJ).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.